Related Experiment Video
Updated: Jun 30, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Same-Day Discharge Following Multiport Robot-Assisted Simple Prostatectomy: A Prospective Feasibility Study of
Narmina Khanmammadova1, Johnny Wang1, Daniel Jiang2
1Department of Urology, University of California, Irvine, Orange, CA.
Urology
|June 28, 2026
Summary
Same-day discharge for multiport robot-assisted simple prostatectomy (MP-RASP) is feasible and safe. This pathway reduces hospital stay and costs, offering favorable outcomes for patients.
Area of Science:
- Urology
- Robotic Surgery
- Surgical Outcomes
Background:
- Robot-assisted simple prostatectomy (RASP) is a common procedure.
- Enhanced Recovery After Surgery (ERAS) protocols aim to optimize patient recovery.
- Same-day discharge (SDD) pathways are being explored to improve healthcare efficiency.
Purpose of the Study:
- To evaluate the feasibility, safety, and cost-effectiveness of a same-day discharge (SDD) pathway for multiport (MP) robot-assisted simple prostatectomy (RASP).
Main Methods:
- Prospective data collection from 48 patients undergoing MP-RASP between July 2021 and August 2025.
- Implementation of an Enhanced Recovery After Surgery (ERAS) protocol.
- Utilization of a bladder neck-sparing technique, transperitoneal approach, and robotic transversus abdominis plane block.
Main Results:
- 83% of patients (40/48) were discharged on the same day; 17% stayed overnight for patient preference or hematuria.
- No perioperative complications were reported; 5% of patients were readmitted within 30 days.
- SDD RASP demonstrated a 33% lower direct cost per case and a higher revenue-to-cost ratio (149% vs. 115%).
Conclusions:
- Multiport robot-assisted simple prostatectomy (MP-RASP) with a same-day discharge (SDD) pathway is safe and feasible.
- This approach leads to reduced hospital stay and significant cost savings.
- Favorable patient outcomes support the adoption of SDD pathways for MP-RASP.
